Four and a half years after one session
What they did
The NYU team re-assessed the surviving participants from its cancer trial at an average of 3.2 and then 4.5 years after a single psilocybin session.
What they found
Reductions in anxiety, depression, hopelessness, demoralization and death anxiety held with large effect sizes. Between 71 and 100 percent attributed positive life changes to the experience.
Worth knowing
Fifteen people who survived a life-threatening cancer diagnosis and agreed to be re-contacted. Survivorship shapes who is left to ask, and self-attributed life change is not an objective measure.
Agin-Liebes et al. Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. Journal of Psychopharmacology, 2020.
Read the sourceKeep reading
end of lifeFifty-one cancer patients, and six months of reliefend of lifePsilocybin rapidly reduced anxiety and depression in cancer patientsend of lifeIn life-threatening illness, anxiety and depression eased and heldThe durability findings here are the ones most often quoted out of context. Read the follow-up periods before you trust a headline about them.
For education, not medical advice. Every write-up links back to the original source.
Nothing here is a claim that our products treat, cure or prevent any condition. Talk to a doctor before changing anything about your health.